Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 31.75
+0.10 (0.32%)
Aug 4, 2026, 1:30 PM CST
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 1.03 billion as of August 4, 2026. Its market cap has decreased by -1.71% in one year.
Market Cap
1.03B
Enterprise Value
811.76M
Revenue
718.58M
Ranking
n/a
PE Ratio
13.41
Stock Price
31.75
ChartMarket Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 1.03B, an increase of 311.38%. That is a compound annual growth rate of 6.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.03B | -3.79% |
| Dec 31, 2025 | 1.07B | 3.13% |
| Dec 31, 2024 | 1.04B | 5.09% |
| Dec 29, 2023 | 988.19M | 10.13% |
| Dec 30, 2022 | 897.32M | -7.68% |
| Dec 30, 2021 | 971.96M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.27B |
| Enimmune | 1.13B |
| BiOptic | 1.12B |
| LabTurbo Biotech | 1.10B |
| U-Neuron Biomedical | 1.09B |
| Bio Preventive Medicine | 1.07B |
| GeneReach Biotechnology | 994.21M |
| Lukas Biomedical | 979.86M |